CD8A and neoplasm: Different from the findings in the NCI9673 study (8), CD8 positive cells in the paracancerous stroma seems not affect treatment response, which implies preexisting CD8 positive immune cells may not be necessary for tumor response to the PD-1 blockade in locally advanced ACSCC.